Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 1/20 | 0.45 |
| ▸ | CTSK | P43235 | 9/20 | 0.44 |
| ▸ | CTSS | P25774 | 8/20 | 0.44 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | APP | P05067 | 1/20 | 0.40 |
| ▸ | BACE1 | P56817 | 2/20 | 0.40 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.38 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29576469 | 0.86 | REN (0.47) | RENCTSKCTSSCTSLCTSB | |
| SCHEMBL23404059 | 0.86 | REN (0.47) | RENCTSKCTSSCTSLCTSB | |
| SCHEMBL21724476 | 0.86 | REN (0.47) | RENCTSKCTSSCTSLCTSB | |
| SCHEMBL7536416 | 0.85 | CTSS (0.49) | RENCTSKCTSSCTSLCTSB | |
| SCHEMBL7536423 | 0.85 | CTSS (0.49) | RENCTSKCTSSCTSLCTSB | |
| SCHEMBL7610438 | 0.83 | CTSS (0.48) | RENCTSKCTSS | |
| SCHEMBL7610443 | 0.83 | CTSS (0.48) | RENCTSKCTSS | |
| SCHEMBL22989798 | 0.82 | CTSD (0.44) | RENCTSKCTSSBACE1 | |
| SCHEMBL1486176 | 0.82 | PPARA (0.47) | CTSKCTSSCTSLCTSB | |
| SCHEMBL1001711 | 0.82 | PPARA (0.47) | CTSKCTSSCTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117083074-A | Pharmaceutical composition for enhancing anticancer effect of anticancer drug | L 基础有限公司 | 2023-11-17 | — | — | CN | disclosed |
| CN-115605495-A | Pharmaceutical composition for preventing or treating cancer | L 基础有限公司（KR） | 2023-01-13 | — | — | CN | disclosed |